4/16/2021 | BKHY | Moody's eyes PPD for upgrade
|
4/15/2021 | BK | S&P ups Cimpress, rates facility BB
|
4/15/2021 | BK | S&P puts PPD on positive watch
|
1/19/2021 | BK | PPD credit facility includes $600 million senior secured revolver
|
1/6/2021 | CLHY | Market Commentary: PPD frees to trade; ERT revises commitment deadline; Utz discloses size, price talk
|
1/6/2021 | BK | Market Commentary: PPD frees to trade; ERT revises commitment deadline; Utz discloses size, price talk
|
1/6/2021 | BK | PPD lifts term B to $3.05 billion, sets spread at Libor plus 225 bps
|
1/4/2021 | CLHY | Market Commentary: PPD shops loan; nThrive TSG, ERT, Women’s Care, Grab Holdings ready deals
|
1/4/2021 | BK | Market Commentary: PPD shops loan; nThrive TSG, ERT, Women’s Care, Grab Holdings ready deals
|
1/4/2021 | BK | PPD launches $2.55 billion term loan B at Libor plus 225-250 bps
|
1/4/2021 | BKHY | Moody’s assigns PPD loans Ba2
|
12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
11/20/2020 | BKHY | S&P upgrades PPD
|
5/21/2020 | BKHY | Moody’s assigns PPD notes B2
|
5/21/2020 | BKHY | S&P rates PPD unit’s notes B
|
5/21/2020 | HYLM | Pharmaceutical Product Development to redeem some 6 3/8% notes
|
3/2/2020 | CLHY | Market Commentary: BMC dips with Compuware acquisition news; Duravant frees up; PPD, Micro Focus postponed
|
3/2/2020 | BK | Market Commentary: BMC dips with Compuware acquisition news; Duravant frees up; PPD, Micro Focus postponed
|
3/2/2020 | BK | PPD withdraws $4.6 billion credit facilities from market
|
2/19/2020 | BKHY | Moody's assigns Ba3 to PPD facilities
|
2/18/2020 | CLHY | Market Commentary: Veeam tweaks loan; Advantage Sales, Sundyne, AVI-SPL, Vizient, Tecomet, HelpSystems set talk
|
2/18/2020 | BK | Market Commentary: Veeam tweaks loan; Advantage Sales, Sundyne, AVI-SPL, Vizient, Tecomet, HelpSystems set talk
|
2/18/2020 | BK | S&P rates PPD loans B+
|
2/18/2020 | BK | PPD readies launch of $4.6 billion credit facilities for Wednesday
|
2/11/2020 | BKHY | S&P assigns PPD B+
|
10/19/2012 | HY | Market Commentary: Dufry, Tervita, Caribbean price to cap $10 billion week; ATP, AMD slide badly
|
10/16/2006 | BT | PPD's net revenues up 14%, income down slightly, president to depart
|
7/21/2006 | BT | PPD reiterated at buy by Jefferies
|
7/18/2006 | BT | Market Commentary: Tercica up 12%, Insmed rises 9%; Neurocrine closes weaker; Pharma Product up; New River deal emerges
|
7/17/2006 | BT | PPD reports record net revenue of $309 million for the second quarter, up 26% from previous year
|
5/2/2006 | BT | PPD to discover biomarkers for PDL BioPharma
|
4/17/2006 | BT | PPD's first quarter net revenue up 22.7% from previous year
|